INC Research Expands European Operations
12 October 2004
Raleigh, NC - INC Research®, a global contract research organization (CRO) specialized in central nervous system (CNS), oncology and pediatric clinical research, announced today it has opened an office in Germany, in Düsseldorf’s state-of-the-art Life Science Center.
INC Research strategically located its facility in the North Rhine-Westphalia region of Germany, to be in close proximity to the more than 130 biotechnology and large pharma companies that are headquartered in the area. In addition, INC Research gains access to a readily available pool of highly qualified and experienced scientific and technical professionals in the internationally recognized city of Düsseldorf and its surrounding metropolitan area.
Caroline Wenzel, MSc., Ph.D., has been appointed as head of clinical operations in Germany. She will be based in INC Research’s new facility in Düsseldorf. Dr. Wenzel brings over 14 years of clinical and scientific experience from the pharma, biotech and contract research industries.
Dr. Wenzel earned her Ph.D. and MSc. from the Free University of Berlin. She is a member of the Association of Clinical Research Professionals, the German Society for Good Research Practice, the German Society for Pharmaceutical Medicine and the German Association for Women in Management.
Kelvin Logan, Ph.D., President of INC Research Europe states, “Having a solid presence in one of the three biggest biotech clusters in Germany adds significantly to our ability to conduct harmonized, top quality clinical research in Europe and as part of an international project. Dr. Wenzel provides a solid scientific and clinical foundation upon which to further evolve INC Research’s therapeutically specialized expertise and technologically advanced service offering in Western, Central and Eastern Europe. Our customers will benefit from the enhanced depth and breadth of our global service capabilities, customized, as always, to meet their unique program requirements.”
The opening of the Düsseldorf office will supplement the already extensive presence of INC Research in Europe, which currently includes operations in Belgium, Bulgaria, Czech Republic, Hungary, Poland, Romania, Russia, Serbia and Montenegro, Spain and the United Kingdom.
INC Research, through its dedicated INC Oncology and INC CNS divisions, manages all aspects of global clinical development programs for pharmaceutical and biotechnology companies developing treatments targeting cancer and central nervous system disorders. In addition, INC Pediatrics offers specialized drug development services for products to treat neonatal, pediatric and adolescent illnesses. Through its DataSpectrum division, INC Research provides a full range of data management, statistical analysis and medical writing services to support global drug development requirements for any therapeutic area. INC Research has offices in North America and Western, Eastern and Central Europe. For more information visit www.incresearch.com.
